Earnings Roundup: Specialty/Smaller Biopharmas See Modest Hit From Pandemic

 
• By Joseph Haas

First quarter financials and COVID-19 impacts from Bausch, Neurocrine, Theravance, Ironwood, Rigel.

Business report
Smaller companies reported some similar Q1 pandemic impacts as their larger peers

More from Earnings

More from Business